A randomized, double-blind clinical study to determine the effect of ANKASCIN 568 plus on blood glucose regulation - PubMed

Diabetes is the fourth major cause of death in Taiwan. High blood glucose can lead to macrovascular diseases, small vessel diseases (retinopathy, kidney disease), and neuropathy. This study aimed to investigate whether Monascus-fermented products (ANKASCIN 568 plus) can regulate blood glucose and bl …分類：pmid:28911684, PMC9332536, doi:10.1016/j.jfda.2016.06.011, Randomized Controlled Trial, Yin-Ruei Wang, Sheng-Fu Liu, Chin-Kun Wang, Blood Glucose / analysis*, Double-Blind Method, Glycated Hemoglobin, Humans, Insulin, Taiwan, PubMed Abstract, NIH, NLM, NCBI, National Institutes of Health, National Center for Biotechnology Information, National Library of Medicine, MEDLINE...